Nitric oxide decreases intestinal haemorrhagic lesions in rat anaphylaxis independently of mast cell activation

Mediators of Inflammation

Volumn 6, Issue 1, 1997, Pages 25-31

  Carvalho Tavares, J ^a   Moreno, A ^a   Sanchez Crespo M ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

CD23; Endotoxin; Inflammation; Necrotizing enterocolitis; Platelet activating factor

Indexed keywords

BUCLADESINE; CD23 ANTIGEN; HISTAMINE; LIPOPOLYSACCHARIDE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; THROMBOCYTE ACTIVATING FACTOR;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ARTICLE; HISTAMINE RELEASE; INTESTINE NECROSIS; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0031055437     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359791893     Document Type: Article

References (45)

1. Alonso A, Carvalho J, Alonso-Torre SR, Nüñez L, Bosca L, Sanchez Crespo M. Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. Evidence in favor of a common signaling mechanism. J Immunol 1995; 154: 6475-6483.
2. Gonzalez-Crussi F, Hsueh W. Experimental model of ischemic bowel necrosis: the role of platelet-activating factor and endotoxin. Am J Pathol 1983; 112: 127-135.
3. Fell BF, Boyne R, Cuthbertson DP. Intestinal lesions following histamine liberation in the rat. J Pathol Bact 1961; 82: 445-452.
4. Fernández-Gallardo S, Gijón MA, García C, Furió V, Liu FT, Sánchez Crespo M. The role of PAF and peptidoleukotrienes in the vascular disturbances of rat passive anaphylaxis. Br J Pharmacol 1992; 105: 119-125.
5. Pellon MI, Steil AA, Furio V, Sánchez Crespo M. Study of the effector mechanism involved in the production of hemorrhagic necrosis of the small intestine in rat passive anaphylaxis. Br J Pharmacol 1994; 112: 1101-1108.
6. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Reviews 1991; 43: 109-141.
7. Mulligan MS, Moncada S, Ward PA. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 1992; 197: 1159-1162.
8. Palmer RMJ, Bridge LN, Foxwell A, Moncada S. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 1992; 105: 11-12.
9. Miller MJS, Grisham MB. Nitric oxide as a mediator of inflammation? You had better believe it. Mediators of Inflammation 1995; 4: 387-396.
10. Boughton-Smith NK, Hutcheson I, Deakin AM, Whittle BJR, Moncada S. Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 1990; 191: 485-488.
11. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
12. Kubes P, Wallace JL. Nitric oxide as a mediator of gastrointestinal mucosal injury? - Say it ain't so. Mediators of Inflammation 1995; 4: 397-405.
13. De Caterina R, Libbi P, Peng HB, Thannickal VJ, Rajavashisth TH, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced activation. J Clin Invest 1995; 96: 60-68.
14. Ferran C, Millam MT, Csizmadia V, Cooper JT, Brostjan C, Bach FH, Winkler H. Inhibition of NF-κB by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun 1995; 214: 212-223.
15. Kubes P, Reinhardt P, Payne D, Woodman RC. Excess nitric oxide does not cause cellular, vascular or mucosal dysfunction in the cat small intestine. Am J Physiol 1995; 269: G34-G41.
16. Salvemini D, Masini E, Anggard E, Mannaioni F, Vane J. Synthesis of nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem Biophys Res Commun 1990; 169: 596-601.
17. Steil AA, García MC, Alonso A, Sánchez Crespo M, Boscá L. Platelet-activating factor is the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis. Br J Pharmacol 1995; 114: 895-901.
18. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990; 346: 274-276.
19. Tracey KJ, Beutler B, Lowry SJ, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey III TJ, Zentella A, Albert J, Shires GT, Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-475.
20. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouazz F, Becherel P, Debre P, Moncada S, Mossalayi MD. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FCεRII/CD23 surface antigen. Proc Natl Acad Sci USA 1995; 92: 7804-7808.
21. Liu FT, Bohn JW, Ferry EL, Yamamoto H, Molinaro CA, Sherman LA, Klinkman N, Katz DJ. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation and characterization. J Immunol 1980; 124: 2728-2734.
22. Hudson L, Hay FC. Antibody interactions with antigen. In: Hudson L, Hay FC, ed. Practical Immunology. Oxford: Blackwell Scientific Publications, 1996; 88-93.
23. Eisen HN. Preparation of purified anti-2, 4-dinitrophenyl antibodies. In: Eisen HN, ed. Methods in Medical Research. Vol. 10. Chicago: Yearbook Medical Publishers, 1964; 94-120.
24. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
25. Leng W, Kuo CG, Qureshi R, Jackchik BA. Role of leukotrienes in vascular changes in the rat mesentery and skin in anaphylaxis. J Immunol 1988; 140: 2361-2368.
26. 35N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
27. Jancar S, Sirois MG, Carrier J, Braquet P, Sirois P. PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis. Inflammation 1991; 15: 347-354.
28. Van Kampen EJ, Ziljtra WG. Standardization of hemoglobinometry. II. The hemoglobincyanide method. Clin Chim Acta 1961; 6: 358-551.
29. Tavares de Lima W, Sirois P, Jancar S. Immune-complex alveolitis in the rat: evidence for platelet-activating factor and leukotrienes as mediators of the vascular lesions. Eur J Pharmacol 1992; 213: 63-70.
30. Shore PA, Burkhalter A, Cohn VH Jr, Pieroni L, Guilloson JJ, Debre P, Arock P. A method for the fluorometric assay of histamine in tissues. J Pharmacol 1959; 127: 182-194.
31. Sánchez Crespo M, Alonso F, Iñarrea P, Alvarez V, Egido J. Vascular actions of synthetic paf-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet-independent mechanism. Immunopharmacology 1982; 4: 173-185.
32. Galli SJ. New concepts about the mast cell. New Engl J Med 1993; 328: 257-265.
33. Hogaboam CM, Befus AD, Wallace JL. Modulation of rat mast cell reactivity by IL-1β. Divergent effects on nitric oxide and platelet-activating factor release. J Immunol 1993; 151: 3767-3774.
34. Kunz H, Mühl H, Walker G, Pfeischifter J. Two distinct signaling pathways trigger the expression of nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci USA 1994; 91: 5387-5391.
35. Hortelano S, Genaro AM, Boscá L. Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. Antagonism with the induction elicited by lipopolysaccharide. J Biol Chem 1992; 267: 24937-24940.
36. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Resp Crit Med 1995; 151: 1894-1899.
37. Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266: G222-G229.
38. Bidri M, Becherel PA, Le Goff L, et al. Involvement of cyclic nucleotides in the immunomodulatory effects of nitric oxide on murine mast cells. Biochem Biophys Res Commun 1995; 210: 507-517.
39. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993; 7: 1293-1299.
40. MacKendrick W, Caplan M, Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res 1993; 34: 807-812.
41. Lander HM, Sehajpal PK, Novogrodsky A. Nitric oxide signaling: a possible role for G proteins. J Immunol 1993; 151: 7182-7187.
42. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78: 931-936.
43. Kim D, Durán W. Platelet-activating factor stimulates protein tyrosine kinase in the hamster cheek pouch microcirculation. Am J Physiol 1994; 268: H399-H403.
44. Schreck R, Rieber RP, Baeuerle PA. Reactive oxygen intermediates as widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10: 2247-2258.
45. Tan X, Sun X, Gonzalez-Crussi FX, Gonzalez-Crussi F, Hsue W. PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCR. Biochim Biophys Acta 1994; 1215: 157-162.